𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Safety of hepatitis B vaccines

✍ Scribed by Arie J. Zuckerman

Book ID
119376545
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
82 KB
Volume
2
Category
Article
ISSN
1477-8939

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Protective efficacy, immunotherapeutic p
Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines
✍ Jane N. Zuckerman πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 99 KB

Hepatitis B vaccines are highly effective and safe and have been incorporated into national immunization programs in over 150 countries. The major humoral immune response is to the common a determinant of the surface antigen protein of the virus. Approximately 5-10% of healthy immunocompetent subjec

Safety and immunogenicity of a recombina
Safety and immunogenicity of a recombinant hepatitis B vaccine
✍ E. Dandolos; A. Roumeliotou-Karayannis; S. C. Richardson; Prof. G. Papaevangelou πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 340 KB

A hepatitis B vaccine produced in yeast by recombinant DNA technology was evaluated using 5-micrograms and 10-micrograms doses in a randomized trial lasting 7 months in 110 male armed forces recruits aged 17-19 years. Results were compared to those of an identical trial of a plasma-derived vaccine.

Comparison of safety and immunogenicity
Comparison of safety and immunogenicity of adw and ayw hepatitis b vaccines
✍ George J. Papaevangelou; Charalambos G. Vissoulis; Anastasia J. Roumeliotou-Kara πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 351 KB

## Abstract The safety and immunogenicity of adw and ayw hepatitis B vaccines were compared in a double‐blind randomized trial in Greek Air Force recruits. One hundred and ten out of 240 eligible nonimmune recruits were randomly selected and allocated to thc two vaccine treatment groups. Two 20‐m̈g